Kim, Amy K.
Hamilton, James P.
Lin, Selena Y.
Chang, Ting-Tsung
Hann, Hie-Won
Hu, Chi-Tan
Lou, Yue
Lin, Yih-Jyh
Gade, Terence P.
Park, Grace
Luu, Harry
Lee, Tai-Jung
Wang, Jeremy
Chen, Dion
Goggins, Michael G. http://orcid.org/0000-0002-4286-2296
Jain, Surbhi
Song, Wei
Su, Ying-Hsiu http://orcid.org/0000-0003-0969-0215
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (K08CA237624, R44CA165312, R43CA165312, R44CA165312, R01CA202769)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 15 October 2021
Revised: 20 December 2021
Accepted: 7 January 2022
First Online: 19 January 2022
Competing interests
: AK is a consultant to AstraZeneca, WS, SJ and SL are shareholders of JBS Science Inc. YHS has received funding from JBS Science, Inc. The remaining authors declare no competing interests.
: The study received ethics approval from Heartland institutional review board (171201-173).
: Not applicable.